V. Steier

发表

In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor

T. Stachyra, A. Bonnefoy, C. Dupuis-Hamelin, 2004 .

KRAS G12C fragment screening renders new binding pockets

M. Mathieu, L. Debussche, M. Lowinski, 2021, Small GTPases.

Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity

Derek J. Wilson, Anthony Sheung, S. Ausar, 2020, Communications Biology.

An Automated Microscale Thermophoresis Screening Approach for Fragment-Based Lead Discovery

D. Breitsprecher, S. Duhr, P. Baaske, 2015, Journal of biomolecular screening.

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.

T. Stachyra, A. Bonnefoy, C. Dupuis-Hamelin, 2004, The Journal of antimicrobial chemotherapy.

Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer.

M. Mathieu, C. García-echeverría, M. Levit, 2019, Journal of medicinal chemistry.

Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity

Derek J. Wilson, Anthony Sheung, S. Ausar, 2020, Communications Biology.

The use of virtual screening and differential scanning fluorimetry for the rapid identification of fragments active against MEK1.

Maryse Lowinski, A. Rak, F. Vallée, 2013, Bioorganic & medicinal chemistry letters.

In vitro and in vivo efficacy of a novel fluoro-ketolide HMR 3562 against enterococci.

A. Bonnefoy, V. Steier, C. Delachaume, 2001, The Journal of antimicrobial chemotherapy.